
Photo: Depositphotos
May 9, 2025, 07:54
Rahul Banerjee: Financial Toxicity Is the First Side Effect of Lenalidomide in Multiple Myeloma
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center at the University of Washington, shared a post on X:
“EXCELLENT Propublica read (by a patient with myeloma) about lenalidomide in Multiple Myeloma and why US costs continue to bankrupt our patients. Financial toxicity is very much the first side effect I discuss with patients as they are starting this drug…”
Read Full Article on propublica.org.
More posts featuring Rahul Banerjee on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 9, 2025, 09:22
May 9, 2025, 09:15
May 9, 2025, 08:15
May 9, 2025, 07:41